Compelling evidence suggests that cerebral deposition of aggregating b
eta-amyloid protein may trigger the neurodegenerative cascades of Alzh
eimer's disease, Down syndrome, and, to a lesser degree, normal aging.
We propose further that free oxygen radicals are critically involved
in beta-amyloidosis. Apart from the established role of free radicals
in other amyloidoses, our proposal is consistent with a large number o
f findings. Among these are (a) the salient relationship of Alzheimer'
s disease with aging and the increase in free oxygen radical liberatio
n with advancing age; (b) biochemical and analytic epidemiologic evide
nce that free radical formation is increased in the disorder; (c) prel
iminary evidence that quenching free radicals slows the clinical progr
ession of Alzheimer's disease; (d) the early and invariable beta-amylo
id accumulation in trisomy 21, a syndrome associated with elevated fre
e radical activity and with concomitant high levels of beta-amyloid pr
ecursor protein; (e) other factors that may be associated with increas
ed liberation of free oxygen radicals and deposition of beta-amyloid p
rotein. Possible mechanisms by which free radicals might modulate beta
-amyloidosis are discussed.